The role of protein kinase C in G1 and G2/M phases of the cell cycle (Review)

International Journal of Oncology

Volumn 12, Issue 1, 1998, Pages 181-186

  Fishman, Daniel D ^a   Segal, Shraga ^a   Livneh, Etta ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

CDK activating kinase; Cell cycle; Cyclin; Cyclin dependent inase; Phorbol esters; Protein kinase C; Retinoblastoma protein

Indexed keywords

PROTEIN SERINE KINASE; PROTEIN KINASE C;

ANIMAL CELL; CANCER; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL DIFFERENTIATION; CELL PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; HUMAN; MITOSIS; PHYSIOLOGY;

ANIMALS; G1 PHASE; G2 PHASE; HUMANS; MITOSIS; PROTEIN KINASE C;

EID: 0031984081     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.12.1.181     Document Type: Review

References (87)

1. Nishizuka Y: Protein kinase C and lipid signaling for sustained cellular responses. FASEB J 9: 486-496, 1995.
2. Stabel S: Protein kinase C - an enzyme and its relatives. Semin Cancer Biol 5: 277-284, 1994.
3. Dekker LV and Parker PJ: PKC - a question of specificity. Trends Biochem Sci 19: 73-77, 1994.
4. Faux MC and Scott JD: More on target with protein phosphorylation: conferring specificity by location. Trends Biochem Sci 21: 312-315, 1996.
5. Borner C, Ueffing M, Jaken S, Parker PJ and Weinstein IB: Two closely related isoforms of protein kinase C produce reciprocal effects. J Biol Chem 272: 78-86, 1995.
6. Jaken S: Protein kianse C isoenzymcs and substrates. Curr Opin Cell Biol 8: 168-173, 1996.
7. Nishizuka Y: The role of protein kinase C in cell surface signal transduction and tumour. Nature 308: 693-698, 1984.
8. Bravo R: Growth factor-responsive genes in fibroblasts. Cell Growth Differ 1: 305-309, 1990.
9. Nishizuka Y: The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature 334: 661-665, 1988.
10. Nishizuka Y: Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258: 607-614, 1992.
11. Hsiao WLW, Gattoni-Celli A and Weinstein IB: Oncogene-induced transformation of C3H 10T1/2 cells is enhanced by tumor promoters. Science 226: 552-555, 1984.
12. Hsiao W, Housey GM, Johnson MD and Weinstein IB: Cells that overproduce protein kinase C are more susceptible to transformation by an activated H-ras oncogene. Mol Cell Biol 9: 2641-2647, 1989.
13. Housey GM, Johnson MD, Hsiao WL, O'Brian CA, Murphy JP and Kirschmeier P: Overproduction of protein kinase C causes disordered growth control in rat. Cell 52: 343-354, 1988.
14. Persons DA, Wilkison WO, Bell RM and Finn OJ: Altered growth regulation and enhanced tumorogenicity of NIH3T3 fibroblasts transfected with protein kinase C-I cDNA. Cell 52: 447-458, 1988.
15. Cacace AM, Nichols-Guadango RS, Krauss RS, Fabbro D and Weinstein IB: The epsilon isoform of protein kinase C is an oncogene when overexpressed in rat fibroblasts. Oncogene 8: 2095-2104, 1993.
16. Han EK, Cacace AM, Sgambato A and Weinstein IB: Altered expression of cyclins and c-fos in R6 cells that overproduce PKCε. Carcinogenesis 16: 2423-2428, 1996.
17. Mischak H, Goodnight JA, Kolch W, Martiny-Baron G, Schaechtle C, Kazanietz MG, Blumberg PM, Pierce JH and Mushinski JF: Overexpression of protein kinase C-δ and ε in NIH3T3 cells induces opposite effects on growth, morphology, anchorage dependence, and tumorogenicity. J Biol Chem 268: 6090-6096, 1993.
18. Watanabe T, Ono Y, Taniyama Y, Hazama K, Igarashi K, Ogita K, Kikkawa U and Nishizuka Y: Cell division arrest induced by phorbol ester in CHO cells overexpressing protein kinase C-δ subspecies. Proc Natl Acad SCi USA 89: 10159-10163, 1992.
19. Livneh E, Shimon T, Bechor E, Doki Y, Schieren I and Weinstein IB: Linking protein kinase C to the cell cycle: ectopic expression of PKGη in NIH3T3 cells alters the expression of cyclins and cdk inhibitors and induces angioneogenesis. Oncogene 12: 1545-1556, 1996.
20. Fukumoto S, Nishizawa Y, Hosoi M, Koyama H, Yamakawa K, Ohno S and Morii H: Protein kinase C δ inhibits the proliferation of vascular smooth muscle cells by supressing G1 cyclin expression. J Biol Chem 272: 13816-13822, 1997.
21. Good NT, Nasser Hajibagheri MA, Warren P and Parker P: Expression of mammalian protein kinase C in Schizosaccharomyces pombe: isotype-specific induction of growth arrest, vesicle formation and endocytosis. Mol Cell Biol 5: 907-920, 1994.
22. Borner C, Filipuzzi I, Weinstein IB and Imber R: Failure of wildtype or a mutant protein kinase C α to transform fibroblasts. Nature 353: 78-80, 1991.
23. Ways DK, Kukoly CA, deVente J, Hooker JL, Bryant WO, Posekany KJ, Fletcher DJ, Cook PP and Parker PJ: MCF-7 breast cancer cells transfected with protein kinase C-α exhibit altered expression of other protein kinase C isoforms and display a more aggressive neoplastic phenotype. J Clin Invest 95: 1906-1915, 1995.
24. Dean N, McKay R, Miraglia L, Howard R, Cooper S, Giddins J, Nicklin P, Meister L, Ziel R, Muller M and Fabbro D: Inhibition of growth of human tumor cell lines in nude mice by an antisense oligonucleotide inhibitor of protein kinase C-α expression. Cancer Res 56: 3499-3507, 1996.
25. Ahmad S, Mineta T, Martuza RL and Glazer RI: Antisense expression of protein kinase C alpha inhibits the growth and tumorigenicity of human glyoblastoma cells. Neurosurgery 35: 904-908, 1994.
26. Pardee AB: G1 events and regulation of cell proliferation. Science 246: 603-608, 1989.
27. Sherr CJ: G1 phase progression: cycling on cue. Cell 79: 551-555, 1994.
28. Heichman KA and Roberts JM: Rules to replicate by. Cell 79: 557-562, 1994.
29. Xiong Y, Zhang H and Beach D: D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 71: 505-514, 1992.
30. Pagano M, Pepperkok R, Verde F, Ansorge W and Draetta G: Cyclin A is required at two points in human cell cycle. EMBO J 11: 961-971, 1992.
31. Pines J: The cell cycle kinases. Semin Cancer Biol 5: 305-313, 1994.
32. Nigg EA: Cyclin dependent kinase 7: at the cross-roads of transcription, DNA repair and cell cycle control? Curr Opin Cell Biol 8: 312-317, 1996.
33. Fisher RP and Morgan DO: A novel cyclin associates with MO16/ CDK7 to form the CDK-activating kinase. Cell 78: 713-724, 1994.
34. KIP1 by diverse signaling pathways in swiss 3T3 cells. Oncogene 14: 1759-1766, 1997.
35. Zhou W, Takuwa N, Kumada M and Takuwa Y: Protein kinase C-mediated bidirectional regulation of DNA synthesis, RB protein phosphorylation, and cyclin-dependent kinases in human vascular endothelial cells. J Biol Chcm 268: 23041-23048, 1993.
36. Zhou W, Takuwa N, Kumada M and Takuwa Y: E2F1, B-myb and selective members of cyclin/cdk subunits are targets for protein kinase C-mediatcd bimodal growth regulation in vascular endothelial cells. Biochem Biophys Res Commun 199: 191-198, 1994.
37. Hamada K, Takuwa N, Zhou W, Kumada M and Takuwa Y: Protein kinase C inhibits the CAK-CDK2 cyclin-dependent cascade and G1/S cell cycle progression in human diploid fibroblasts. Biochim Biophys Acta 1310: 149-156, 1996.
38. Kosaka C, Sasaguri T, Masuda J, Zen K, Shimokado K, Yokota T and Ogata J: Protein kinase C-mediated inhibition of cyclin A expression in human vascular endothelial cells. Biochem Biophys Res Commun 193: 991-998, 1993.
39. Sasaguri T, Ishida A, Kosaka C, Nojima H and Ogata J: Phorbol ester inhibits the phosphorylation of the retinoblastoma protein without supression cyclin-D associated kinase in vascular smooth muscle cells. J Biol Chem 271: 8345-8351, 1996.
40. Sasaguri T, Kosaka C, Hirata M, Masuda J, Shimokado K, Fujishima M and Ogata J: Protein kinase C mediated inhibition of vascular smooth muscle cells proliferation: the isoforms that may mediate G1/S inhibition. Exp Cell Res 208: 311-320, 1993.
41. Huang TS, Duyster J and Wang JY: Biological response to phorbol ester determined by alternative G1 pathways. Proc Natl Acad Sci USA 92: 4793-4797, 1995.
42. Man EK, Cacace AM, Sgambato A and Weinstein IB: Altered expression of cyclins and c-fos in R6 cells that overproduce PKCε. Carcinogenesis 16: 2423-2428, 1996.
43. Muller R: Transcripional regulation during mammalian cell cycle. Trends Genet 11: 173-178, 1995.
44. Weinberg RA: The retinoblastoma protein and cell cycle control. Cell 81: 323-330, 1996.
45. Weinberg RA: E2F and cell proliferation: a world turned upside down. Cell 85: 457-459, 1996.
46. Nakaigawa N, Hirai S, Muzuno K, Shuin T, Hosaka M and Ohno S: Differential effects of overexpression of PKCα and PKCδ/ε on cellular E2F activity in late G1 phase. Biochem Biophys Res Commun 222: 95-100, 1996.
47. Schnier JB, Nishi K, Goodrich DW and Bradbury EM: G1 arrest and down-regulation of cyclin E/cyclin-dependent kinase 2 by the protein kinase inhibitor staurosporine are dependent on the retinoblastoma protein in the bladder carcinoma cell line 5637. Proc Natl Acad Sci USA 93: 5941-5946, 1996.
48. Takenaka I and Kley N: Regulation of sequence specific DNA binding function of p53 by PKC and protein phosphatases. J Biol Chem 270: 5405-5411, 1995.
49. Arrowsmith CH and Morin P: New insights into p53 function from structural studies. Oncogene 12: 1379-1385, 1996.
50. Levine AJ, Perry ME, Chang A, Silver D, Dittmer M, Wu M and Welsh D: The 1993 Walter Huber lecture: the role of p53 tumour supressor gene in tumorigenesis. Br J Cancer 69: 409-416, 1994.
51. Levine AJ: p53, the cellular gatekeeper for growth and division. Cell 88: 325-331, 1997.
52. Sherr CJ: Cancer cell cyles. Science 274: 1672-1677, 1996.
53. Hupp TR, Sparks A and Lane DP: Small peptides activate the latent sequence specific binding activity of p53. Cell 83: 237-245, 1995.
54. Balagurumoorthy P and Harrington DE: Four p53 binding domain peptides bind natural p53 response element and bend DNA. Proc Natl Acad Sci USA 92: 8591-8595, 1995.
55. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B: WAF-1, a potential mediator of p53 tumor supression. Cell 75: 817-825, 1993.
56. Bischoff JR, Friedman PN, Marshok DR, Prives C and Beach D: Human p53 is phosphorylated by p60-cdc2 and cyclin B-cdc2. Proc Natl Acad Sci USA 87: 4766-4770, 1990.
57. Hupp TR and Lane DP: Allosteric activation of latent p53 tetramers. Curr Biol 4: 865-875, 1994.
58. Baudier J, Delphin C, Grunwald, Khochbin S and Lawrence JJ: Characterization of the tumor supressor protein p53 as a protein kinase C substrate and a s100b-binding protein. Proc Natl Acad Sci USA 89: 11627-1163, 1992.
59. Ulrich SJ and Apella E: Posttranslational modifications of p53 by phosphorylation. J Biol Chem 267: 15259-15262, 1992.
60. Delphin C and Baudier J: The protein kinase C activator, phorbol ester, cooperates with wild-type p53 species in ras-transformed embryo fibroblasts growth arrest. J Biol Chem 47: 29579-29587, 1994.
61. Takenaka I, Morin F, Scizinger BR and Kley N: Regulation of sequence soecific DNA-binding function of p53 by protein kinase C and protein phosphatases. J Biol Chem 270: 5405-5411, 1995.
62. Milne DM, McKendrick L, Deacon E, Lord JM and Meek DW: Murine p53 is phosphorylated within p42I epitope by PKC in vivo, even after stimulation with phorbol ester TPA. Oncogene 13: 205-201, 1996.
63. Zeng YX and El-Deiry WS: Regulation of p21-WAF1? CIP1 expression by p53 independent pathways. Oncogene 12: 1557-1564, 1996.
64. Dunphy WG: The decision to entry mitosis. Trends Cell Biol 4: 202-207, 1994.
65. Lee M and Nurse P: Cell cycle control genes in fission yeast and mammalian cells. Trends Genet 4: 287-290, 1988.
66. Igarashi M, Nagaya A, Jinno S, Suto K and Okayama H: Weel+ like gene in human cells. Nature 353: 80-83, 1991.
67. cdc2. Cell Growth Differ 3: 485-494, 1992.
68. Kosaka C, Sasaguri T, Ishida A and Ogata J: Cell cycle arrest in the G2 phase induced by phorbol esther and diacylglycerol in vascular endothelial cells. Am J Physiol 270 (1 Pt1): C170-178, 1996.
69. Thompson LJ and Fields AP: PKCßII is required for the G2/M phase transition of cell cycle. J Biol Chem 271: 15045-15053, 1996.
70. Tchou WW, Rom WN and Tchou-Wong KM: Novel form of p21(WAF1/CIP1/SDI1) protein in phorbol ester induced G2/M arrest. J Biol Chem 271: 29556-29560, 1996.
71. Earth H and Kinsel V: Phorbol esther TPA rapidly prevents activation of p34cdc2 histone H1 kinase and concomitantly the transition from G2 phase to mitosis in synchronized HeLa cells. Exp Cell Res 212: 282-288, 1994.
72. Hass R, Gunji H, Hirano M, Weichselbaum R and Kufe D: Phorbol esther induced monocytic differentiation is associated with G2 delay and downregulation of CDC25 expression. Cell Growth Differ 4: 159-166, 1993.
73. Griffiths G, Garrone B, Deacon E, Owen P, Pongracz J, Mead G, Bradwell A, Waters D and Lord J: The polyether Bistratene A activates protein kinase C-δ and induces growth arrest in HL60 cells. Biochem Biophys Res Commun 222: 802-808, 1996.
74. Nigg EA: Assembly and cell cycle dynamics of the nuclear lamina. Semin Cell Biol 3: 245-253, 1992.
75. Eggert M, Radomski N, Linder D, Tripier D, Traub P and Jost E: Identification of novel phosphorylation sites in murine A-type lamins.Eur J Biochem 213: 659-671, 1993.
76. Hocevar BA, Burns DJ and Fields AP: Identification of protein kinase C phosphorylation sites on human lamin B. Potential role of PKC in nuclear lamina structural dynamics. J Biol Chem 268: 7545-7552, 1993.
77. Goss VL, Hocevar BA, Thompson LJ, Stratton CA, Burns DJ and Fields AP: Identification of nuclear ßII protein kinase C as a mitotic lamin kinase. J Biol Chem 269: 15045-15053, 1994.
78. Watanabe M, Chen CY and Levin DE: Saccharomyces cerevisiae PKC1 encodes a protein kinase C (PKC) homologue with a substrate specificity similar to that of mammalian PKC. J Biol Chem 269: 16829-16836, 1994.
79. Antonsson B, Montessuit S, Friedli L, Payton MA and Paravicini G: Protein kinase C in yeast. Characteristics of the Saccharomyces cerevisiae PKC1 gene product. J Biol Chem 269: 16821-16828, 1994.
80. Paravicini G, Cooper M, Friedli L, Smith DJ, Carpentier JL, Klig LS and Payton MA: The osmotic integrity of the yeast cell requires a functional PKC1 gene product. Mol Cell Biol 12: 4896-4905, 1992.
81. Levin DE, Fields FO, Kunisawa R, Bishop JM and Thorner J: A candidate protein kinase C gene is requierd for the S. cerevisiae cell cycle. Cell 62: 213-224, 1990.
82. Marini NJ, Meldrum E, Buehrer B and Reed SI: A pathway in the yeast cell division cycle linking PKC1 to activation of CDC28 at START. EMBO J 15: 3040-3052, 1996.
83. Kolch W, Heidecker G, Kochs G, Hummel R, Vahidi H, Mischak H, Finkenzeller G, Marme D and Rapp UR: Protein kinase C alpha activates RAF-I by direct phosphorylation. Nature 364: 249-252, 1993.
84. Cai H, Smola U, Wixler V, Eisenmann-Tappe I, Diaz-Meco MT, Moscat J, Rapp U and Cooper GM: Role of diacylglycerol-regulated protein kinase C isotypes in growth factor activation of Raf-1 protein kinase. Mol Cell Biol 17: 732-741, 1997.
85. Huge H and Sarre T: Protein kinase C isoenzymes: divergence in signal transduction? Biochem J 291: 329-343, 1993.
86. Winston JT, Coats SR, Wang YZ and Pledger WJ: Regulation on the cell cycle machinery by oncogenic ras. Oncogene 12: 127-134, 1996.
87. Arber N and Weinstein IB: Increased expression of cycin D1 and the Rb tumor supressor gene in Ki-ras transformed rat embryocytes. Oncogene 12: 1903-1908, 1996.